Research & Market Insights

SHERIDAN, WYOMING - April 4, 2026 - Dental clinicians managing deep cavity restorations and endodontic retreatment decisions now have a richer evidence base to draw from, as Septodont USA's February 2026 clinical newsletter consolidates two-year trial outcomes for BioRoot® Flow and four documented case studies applying Biodentine® in the Bio-Bulk Fill technique for indirect restorations.

Biodentine Bio-Bulk Fill: four clinical cases document deep cavity restoration

Septodont's Case Studies Collection 28 presents workflows from four clinicians who used Biodentine®'s dentine-like mechanical and biological properties to restore deep cavities using the Bio-Bulk Fill technique. The cases extend the application of the material to symptomatic cracked teeth - a notoriously difficult clinical scenario where pulp status is uncertain and cavity geometry is irregular.

SHERIDAN, WYOMING - April 2, 2026 - Network architects and compliance teams designing next-generation infrastructure face a binding constraint: 6G Integrated Sensing and Communications (ISAC) systems introduce sensing capabilities that existing security and privacy frameworks do not cover, and ETSI's newly published GR ISC 004 defines the technical and non-technical requirements that vendors and operators must address before these systems can be responsibly deployed.

What ETSI GR ISC 004 covers

The European Telecommunications Standards Institute's Industry Specification Group on Integrated Sensing and Communications published ETSI GR ISC 004, a structured report cataloguing 19 key issues spanning security, privacy, trustworthiness, and sustainability in 6G ISAC environments. Of those 19 issues, 15 address security and privacy, while the remaining four focus on sustainability dimensions unique to systems that sense as well as communicate.

SHERIDAN, WYOMING - March 31, 2026 - Grinding manufacturers face a more data-driven operating model in 2026 as cooling lubricant management moves from a maintenance task into a direct lever for energy use, surface quality, uptime and scrap reduction. VDW highlights this shift through research and industrial practice around requirement-based coolant supply, where sensor data, standardized machine connectivity and cloud-based service platforms are used to stabilize grinding conditions and support more autonomous production.

SHERIDAN, WYOMING - March 31, 2026 - European hospitals evaluating 2026 imaging, intervention, and workforce plans now have a new validation pathway for AI-assisted neurovascular and oncology procedures as the SHERPA consortium starts seven clinical studies focused on workflow automation, precision support, and staff-pressure reduction in minimally invasive care. The four-year project has a total budget of EUR 21.5 million, is coordinated by Philips, and is co-funded by the EU Innovative Health Initiative and industry partners. Its work targets minimally invasive treatment workflows for brain aneurysms, liver tumors, and lung biopsy settings where specialized expertise is limited and procedure complexity is high.

SHERIDAN, WYOMING - March 13, 2026 - Roche has reported positive Phase II results for petrelintide, an amylin analog being developed for people living with overweight and obesity. According to the company, petrelintide delivered up to 10.7% mean body weight reduction at week 42 compared with 1.7% for placebo, with a p-value of less than 0.001. Roche also said the maximally effective dose showed placebo-like tolerability, with no vomiting cases and no treatment discontinuations due to gastrointestinal adverse events. For the obesity treatment market, the update is relevant because efficacy and tolerability remain central to prescribing, adherence and competitive positioning.

SHERIDAN, WYOMING - December 4, 2025 - Life sciences dealmaking is regaining momentum after a period of macroeconomic caution, but new research from West Monroe shows that transaction volume alone will not determine who comes out ahead. Instead, success in the next wave of M&A will hinge on execution speed, AI and digital maturity, and the ability to integrate people and cultures without losing focus on the deal thesis.

Dealmaking Rebounds, but the Rules Have Changed

West Monroe's report, The Next Wave of Life Sciences M&A: Navigating Policy, Power, and Progress, combines practitioner insight with a survey of 250 private equity firms and strategic acquirers in life sciences. The findings point to a clear rebound in activity: 68% of respondents expect more acquisitions in the next two years, while only 7% plan no deals at all.